273 related articles for article (PubMed ID: 6640877)
1. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.
DiMarco JP; Sellers TD; Berne RM; West GA; Belardinelli L
Circulation; 1983 Dec; 68(6):1254-63. PubMed ID: 6640877
[TBL] [Abstract][Full Text] [Related]
2. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
Belhassen B; Glick A; Laniado S
Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581
[TBL] [Abstract][Full Text] [Related]
3. Intravenous adenosine triphosphate disodium: its efficacy and electrophysiologic effects on patients with paroxysmal supraventricular tachycardias.
Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
Pacing Clin Electrophysiol; 1986 May; 9(3):401-10. PubMed ID: 2423982
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.
diMarco JP; Sellers TD; Lerman BB; Greenberg ML; Berne RM; Belardinelli L
J Am Coll Cardiol; 1985 Aug; 6(2):417-25. PubMed ID: 4019929
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic effects of intravenous adenosine triphosphate disodium on the paroxysmal supraventricular tachycardias.
Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
Jpn Heart J; 1985 Jan; 26(1):33-43. PubMed ID: 4009958
[TBL] [Abstract][Full Text] [Related]
6. Adenosine in treating cardiac arrhythmias.
Zehender M; Jeron A; Faber T; Brunner M; Just H
J Auton Pharmacol; 1996 Dec; 16(6):329-31. PubMed ID: 9131409
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal supraventricular tachycardia with Wenckebach block: evidence for reentry within the upper portion of the atrioventricular node.
DiMarco JP; Sellers TD; Belardinelli L
J Am Coll Cardiol; 1984 Jun; 3(6):1551-5. PubMed ID: 6715711
[TBL] [Abstract][Full Text] [Related]
8. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
[TBL] [Abstract][Full Text] [Related]
9. Adenosine: an effective and safe antiarrhythmic drug in pediatrics.
Paul T; Pfammatter JP
Pediatr Cardiol; 1997; 18(2):118-26. PubMed ID: 9049125
[TBL] [Abstract][Full Text] [Related]
10. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
Prystowsky EN; Niazi I; Curtis AB; Wilber DJ; Bahnson T; Ellenbogen K; Dhala A; Bloomfield DM; Gold M; Kadish A; Fogel RI; Gonzalez MD; Belardinelli L; Shreeniwas R; Wolff AA
J Am Coll Cardiol; 2003 Sep; 42(6):1098-102. PubMed ID: 13678937
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.
Calkins H; Sousa J; el-Atassi R; Rosenheck S; de Buitleir M; Kou WH; Kadish AH; Langberg JJ; Morady F
N Engl J Med; 1991 Jun; 324(23):1612-8. PubMed ID: 2030717
[TBL] [Abstract][Full Text] [Related]
12. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
[TBL] [Abstract][Full Text] [Related]
13. Antidromic tachycardia utilizing decremental, latent accessory atrioventricular fibers: differentiation from adenosine-sensitive ventricular tachycardia.
Goldberger JJ; Pederson DN; Damle RS; Kim YH; Kadish AH
J Am Coll Cardiol; 1994 Sep; 24(3):732-8. PubMed ID: 8077546
[TBL] [Abstract][Full Text] [Related]
14. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
[TBL] [Abstract][Full Text] [Related]
15. Adenosine-induced non-sustained polymorphic ventricular tachycardia.
Romer M; Candinas R
Eur Heart J; 1994 Feb; 15(2):281-2. PubMed ID: 8005132
[TBL] [Abstract][Full Text] [Related]
16. Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility.
Sharma AD; Klein GJ; Yee R
Am J Med; 1990 Apr; 88(4):337-43. PubMed ID: 2327421
[TBL] [Abstract][Full Text] [Related]
17. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
18. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
Sellers TD; Kirchhoffer JB; Modesto TA
Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG
Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093
[TBL] [Abstract][Full Text] [Related]
20. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
Viskin S; Belhassen B; Sheps D; Laniado S
Am J Cardiol; 1992 Oct; 70(9):879-85. PubMed ID: 1529941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
